ArticleBiomedicines2023

Estimating the Prevalence and Characteristics of Patients Potentially Eligible for Lipoprotein(a)-Lowering Therapies in a Real-World Setting.

Arrigo F G Cicero et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.